Cleared Special

LINQ II? Insertable Cardiac Monitor (ICM)

K240693 · Medtronic, Inc. · Cardiovascular
Mar 2024
Decision
15d
Days
Class 2
Risk

About This 510(k) Submission

K240693 is an FDA 510(k) clearance for the LINQ II? Insertable Cardiac Monitor (ICM), a Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection) (Class II — Special Controls, product code MXD), submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on March 28, 2024, 15 days after receiving the submission on March 13, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1025.

Submission Details

510(k) Number K240693 FDA.gov
FDA Decision Cleared SESE
Date Received March 13, 2024
Decision Date March 28, 2024
Days to Decision 15 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MXD — Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)
Device Class Class II — Special Controls
CFR Regulation 21 CFR 870.1025

Similar Devices — MXD Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)

All 31
Assert-IQ (DM5100)
K253516 · Abbott Medical · Dec 2025
Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000)
K251221 · Abbott · Sep 2025
LUX-Dx II Insertable Cardiac Monitor (M302); LUX-Dx II+ Insertable Cardiac Monitor (M312)
K252593 · Boston Scientific Corporation · Sep 2025
LINQ II Insertable Cardiac Monitor
K233562 · Medtronic, Inc. · Dec 2023
LINQ II? Insertable Cardiac Monitor (LNQ22)
K233320 · Medtronic, Inc. · Oct 2023
LUX-Dx II (M302); LUX-Dx II+ (M312)
K231328 · Boston Scientific Corp · Aug 2023